Join to view full profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-4500
Fax+1 617-632-5370
Dr. Freed-Pastor is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2013 - 2021
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2013 - 2016
Columbia University Vagelos College of Physicians and SurgeonsClass of 2013
Certifications & Licensure
MA State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsDeep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer.André Forjaz, Hengameh Mojdeganlou, Alens Valentin, Meredith Wetzel, Dmitrijs Lvovs
Biorxiv. 2026-03-05 - 39 citationsPancreatic cancer-restricted cryptic antigens are targets for T cell recognition.Zackery A Ely, Zachary J Kulstad, Gurcan Gunaydin, Sudarsana Addepalli, Eva K Verzani
Science. 2025-05-08 - 40 citationsA prime editor mouse to model a broad spectrum of somatic mutations in vivo.Zackery A Ely, Nicolas Mathey-Andrews, Santiago Naranjo, Samuel I Gould, Kim L Mercer
Nature Biotechnology. 2024-03-01
Press Mentions
New Algorithm to Predict SchizophreniaAugust 8th, 2021
Experts Say Zoonotic Threats Must Be Integrated into Global Health Security PlanningAugust 8th, 2021
New Drug Combo Eliminates Pancreatic Cancer in MiceAugust 7th, 2021
Grant Support
- Elucidating the molecular and cellular mechanisms of immune evasion in pancreatic cancerDANA-FARBER CANCER INST2022–2027
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










